Skip to main content

Month: June 2023

Amedisys and Optum to Combine, Advancing Value-Based Care for Patients 

BATON ROUGE, La., June 26, 2023 (GLOBE NEWSWIRE) — Amedisys (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care, and Optum, a diversified health services company, have agreed to combine. The agreement calls for the acquisition of Amedisys’s outstanding common stock in an all-cash transaction for $101 per share. The combination of Amedisys with Optum unites two organizations dedicated to providing compassionate, value-based comprehensive care to patients and their families. The agreement is subject to Amedisys shareholder approvals, regulatory approvals and other customary closing conditions. Additional Information and Where to Find It In connection with the proposed transaction, Amedisys, Inc. (“Amedisys”) will file relevant materials with the United States Securities and Exchange Commission (the “SEC”),...

Continue reading

Form 8.3 – [ CENKOS SECURITIES PLC] – 23 06 2023 – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree CENKOS SECURITIES PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

LiveOne’s PodcastOne Signs Binding LOI to Acquire Fantasy Guru

– Purchase Price 500-800K Shares in PodcastOne at $8 – Adds 24K Subscribers at $8+ ARPU – Expect to be Immediately Accretive Adding $2.5+ Million Revenues and over $600k in EBITDA – PodcastOne Enters Booming Fantasy Sports Market Valued at Over $20 Billion – Brings Fantasy Guru’s 20 Expert Creators Across Radio/Podcasts and 300K Fans of Fantasy Sports – Artificial Intelligence Including ChatGPT Powers Fantasy Guru to Assist in the Predictions of Player Props and Building of Effective Daily Fantasy Sports Lineups LOS ANGELES, CA, June 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — LiveOne (NASDAQ: LVO), an award-winning, creator-first, music, entertainment and technology platform, announced today that it has signed a binding letter of intent to acquire 100% of Guru Fantasy Sports, Inc....

Continue reading

Form 8.3 – [EMIS GROUP PLC] 23 06 2023 – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree EMIS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Kartoon Studios Transfers Listing to NYSE American – Begins Trading Under New Ticker Symbol ‘TOON’

Iconic ‘STAN LEE’ will Ring the NYSE Opening Bell This Morning BEVERLY HILLS, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Kartoon Studios, (NYSE American: TOON) today announced that the Company has officially changed its name from Genius Brands International to Kartoon Studios and, effective at the opening of trading this morning, has transferred its listing from the Nasdaq Capital Market (“Nasdaq”) to the NYSE American exchange (“NYSE American”). The Company’s common stock will trade under the new trading symbol, “TOON,” and a new CUSIP number, 37229T 509. ‘STAN LEE,’ via animation, will ring the opening bell of the NYSE American today at 9:30 AM ET, reflecting Kartoon Studios’ emphasis on STAN LEE-created IP going forward, through its controlling interest in Stan Lee Universe, LLC. Anyone that would like to join in on the celebration...

Continue reading

Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices

IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that it has been added to the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted May 19. Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of April 28, 2023, ranking them by total market capitalization. Membership in the US all-cap Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000® Index as well...

Continue reading

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

DSS Shareholders of Record on June 30 to Receive 4 Shares for Every 1 DSS Share ROCHESTER, N.Y., June 26, 2023 (GLOBE NEWSWIRE) — DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and development to build shareholder value through periodic spinoffs, has filed for the distribution of a special stock dividend to DSS Inc. shareholders of record on June 30 for distribution on July 14, 2023. DSS shareholders of record as of 4:00 p.m. ET on June 30, 2023 (the “record date”) will receive four (4) shares of Impact Biomedical, Inc. for every one (1) share of DSS. About Impact BioMedical, Inc. Impact BioMedical, Inc. (“Impact BioMedical”) is a wholly owned subsidiary of DSS. Impact BioMedical leverages its scientific expertise and...

Continue reading

Shawcor Ltd., dba Mattr Infratech Announces the Early Renewal and Expansion of Its Normal Course Issuer Bid

TORONTO, June 26, 2023 (GLOBE NEWSWIRE) — Shawcor Ltd., dba Mattr Infratech (“Mattr” or the “Company”) (TSX: MATR), today announced that it has terminated its existing normal course issuer bid (the “Existing Bid”), which commenced on September 26, 2022 and had an expiry date of September 25, 2023, and the Toronto Stock Exchange (the “TSX”) has approved the Company’s notice of intention to renew its normal course issuer bid (the “New Bid”) for common shares of the Company (the “Common Shares”). Under the Existing Bid, the Company purchased for cancellation a total of 1,515,000 Common Shares, through the facilities of the TSX or by such other permitted means, out of the 5,685,630 Common Shares it was authorized to repurchase, for an aggregate repurchase price of approximately $17,481,432.21 million and at a volume weighted average...

Continue reading

Energy Vault Selects Chart Industries Hydrogen Fueling Solution for Largest Green Hydrogen Long-Duration Energy Storage System in the U.S.

ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a leading global engineering design and manufacturer of highly engineered equipment servicing multiple applications in the clean energy and industrial gas markets, announced that Energy Vault Holdings, Inc. (NYSE: NRGV) (“Energy Vault”), a leader in sustainable grid-scale energy storage solutions, has selected Chart as the supplier of an integrated liquid hydrogen storage and fuel delivery system for a green hydrogen long-duration energy storage system (BH-ESS) used in conjunction with a utility-scale battery to provide back-up power to the city of Calistoga, California. Chart’s integrated fuel system includes liquid hydrogen (LH2) bulk storage tanks and vaporization equipment used to store the liquid hydrogen on-site and feed to the fuel cells...

Continue reading

OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe

Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants for the diagnosis of antibiotic resistant bacteria. The opposition division of European Patent Office ruled to maintain the patent as granted with minor modifications.ROCKVILLE, Md., June 26, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, and OpGen subsidiary, Ares Genetics, which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), announced today that one of its key patents under opposition has been successfully maintained. The patent with the title GENETIC RESISTANCE PREDICTION AGAINST ANTIMICROBIAL DRUGS IN MICROORGANISM...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.